Form 4 Filing for Evommune, Inc. - Pena Luis C. Sells Common Stock
2026-06-24SEC Filing 4 (0001620548-26-000007)
On June 22, 2026, Luis C. Pena, President & CEO and Director of Evommune, Inc., sold 7,438 shares of common stock. The sale was conducted under a Rule 10b5-1 trading plan adopted on March 2, 2026. The shares were sold at a weighted average price of $22.71, with individual transactions ranging from $22.50 to $22.99. Following this transaction, Pena beneficially owns 630,458 shares of Evommune, Inc. common stock. This filing is a Form 4, indicating a change in beneficial ownership.